Copy
Hello <<First Name>>! It’s Helen from Labiotech.eu, bringing you the best news on biotech in Europe this week. 😉
Top Stories of the Week

Headlines
Sponsored
Jobs & Inside Labiotech
Refresh
Upcoming Events
SMi Group are proud to announce the 9th Annual Orphan Drugs and Rare Diseases Conference, taking place on October 15th-16th, 2019 in London, UK. The 2019 agenda features various key presentations by leading solution providers, biotechnology companies, clinical researchers, regulatory professionals and charity leaders discussing possible ways to accelerate orphan drug development and access to rare disease patients, including the introduction of recent technologies and products to help aid the access of orphan drugs.
The largest-ever Healthcare Investor Conference in Portugal will take place on November 8th, 2019, as part of the Lisbon Investor Conference, and is being organized by Hovione Capital. We will showcase several startups revolutionizing healthcare and 11 of the largest European life sciences Investors with a total of €6.0 Billion under management. Our attendees will also benefit from a 20% discount towards a Web Summit ticket happening that same week.
Event calendar
What are you doing to enjoy the last few days of summer? 🌞
Made with ❤️ and 🍺 in Berlin.
Over 10,000 biotech fans are reading our newsletter. Forward it to a lucky friend or colleague to help keep them informed!

Did someone forward you this great newsletter? 

Click here now to subscribe
Facebook
Twitter
LinkedIn
Instagram
YouTube

Want to change how you receive these emails?
You can update your preferences or unsubscribe here



Labiotech UG (haftungsbeschränkt), Schönhauser Allee 83 10439 Berlin DE
Email: contact-at-
labiotech.eu
Managing Directors (Vertretungsberechtigte Geschäftsfüh-
rer): Philip Hemme & Joachim Eeckhout
Commercial Register: District Court Charlottenburg (
Amtsge- richt Charlottenburg), Berlin
Company Registration Number (Handelsregisternummer): HRB 168244 B
VAT ID No.: DE300856735
Legally responsible for the content pursuant to Section 55(2) of the German Interstate Treaty on Broadcasting (Rundfunk-
staatsvertrag – RStV): Philip Hemme and Joachim Eeckhout